ShareValue.ai

ShareValue scores for MEDEZE.BK: Valuation 11, Quality 62, Growth 42, Health 60.

MEDEZE.BK
SET

Medeze Group PCL

THB 6.60(+0.76%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 7%
Valuation
11
Overvalued
Price vs Value
Quality
62
Moderate
Business Strength
Growth
42
Moderate
Revenue & Earnings
Health
60
Moderate
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Score Analysis

AI Investment Thesis

Data as of:Jul 13, 2026
|
Last calculated:Jul 13, 2026